XELJANZ 5 mg/1

XELJANZ 5 mg is a medication containing tofacitinib, used for managing specific inflammatory conditions. This oral tablet is designed to help reduce symptoms and improve quality of life.

XELJANZ 5 mg is primarily used for the treatment of moderate to severe rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis in adults. Tofacitinib, the active ingredient, works by modulating the immune system to reduce inflammation. Patients often wonder, 'What is XELJANZ used for?' It is typically prescribed when other treatments have not been effective or are not well-tolerated.

Common effects of XELJANZ 5 mg may include upper respiratory tract infections, headache, and nausea. Some users also report fatigue and diarrhea. These effects can vary from person to person and are not experienced by everyone who takes the medication.

XELJANZ 5 mg should be handled with care, especially for individuals with a history of infections or blood clots. It is important to follow the advice of a healthcare provider regarding monitoring and regular check-ups. Patients should also be aware of the potential risks associated with long-term use.

XELJANZ 5 mg may interact with certain medications, including those that affect the immune system or blood clotting. Alcohol and other substances that suppress the immune system should be used with caution. Always inform your healthcare provider about all medications and supplements you are taking.